Apart from the abovementioned prognostic biomarkers, there were another two DElncRNAs (GVINP1 and PCED1B-AS1) and 15 DEmRNAs (BIN2, CCDC69, CCR4, CD3E, CD5, DOCK2, F2RL2, HLA-E, JCHAIN, LRRC15, NCKAP1L, PIK3CD, SFRP1, SPN, and TNFAIP3) that contributed to the overall survival of patients with luminal BC. Here, F2RL2 is linked to breast cancer.